Status:
COMPLETED
Cell Mediated Immunity in Older Adults
Lead Sponsor:
Vanderbilt University
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Immunity to Influenza Vaccine
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This study is to study the immune response to the flu vaccine in people 65 years old and older. Only adults 65 years old and older and who are getting their flu vaccine are being asked to join in this...
Detailed Description
During the 2010-2011 influenza season, approximately 100 adults ≥65 years of age will be enrolled. After consent, blood and serum will be collected and then subjects will be randomized to either stand...
Eligibility Criteria
Inclusion
- healthy
- aged 65+ years
Exclusion
- \<65 years
- influenza vaccine allergy
- Guillain-Barre
- weight \<110 pounds
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT01189123
Start Date
August 1 2010
End Date
August 1 2013
Last Update
April 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37215